Day One, Taking a Page from Rare Disease Playbook, Raises $60M for Kids With Cancer

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more.


You may also like

“You Went to SITC and All You Got Was This TR Post? (Part 2)
You Went to SITC And All You Got Was This TR Post? (Part 1)
AACR Reflections: Genomics Adapts to I-O World, Scientists Stand Up, and Re-Thinking How to Fight Early-Stage Cancer